ASSET | DATE | % RETURN |
---|---|---|
Osisko Development (ODV) | 10/1/2019 - 12/31/2019 | 2,656% |
Sobr Safe (SOBR) | 10/1/2019 - 12/31/2019 | 971.43% |
Oncolytics Biotech (ONCY) | 10/1/2019 - 12/31/2019 | 698.52% |
FuelCell Energy (FCEL) | 10/1/2019 - 12/31/2019 | 684.38% |
Battalion Oil (BATL) | 10/1/2019 - 12/31/2019 | 572.5% |
Agape ATP Corporation Common Stock (ATPC) | 10/1/2019 - 12/31/2019 | 560% |
Pennant (PNTG) | 10/1/2019 - 12/31/2019 | 437.72% |
Axsome Therapeutics (AXSM) | 10/1/2019 - 12/31/2019 | 410.42% |
Kodiak Sciences (KOD) | 10/1/2019 - 12/31/2019 | 400.35% |
Clearside Biomedical (CLSD) | 10/1/2019 - 12/31/2019 | 339.39% |
Cassava Sciences (SAVA) | 10/1/2019 - 12/31/2019 | 336.97% |
Neurogene (NGNE) | 10/1/2019 - 12/31/2019 | 323.37% |
Relmada Therapeutics (RLMD) | 10/1/2019 - 12/31/2019 | 290% |
Aurinia Pharmaceuticals (AUPH) | 10/1/2019 - 12/31/2019 | 277.28% |
Mersana Therapeutics (MRSN) | 10/1/2019 - 12/31/2019 | 262.66% |
Castellum (CTM) | 10/1/2019 - 12/31/2019 | 256.67% |
Matinas BioPharma (MTNB) | 10/1/2019 - 12/31/2019 | 243.94% |
Kiora Pharmaceuticals (KPRX) | 10/1/2019 - 12/31/2019 | 219.11% |
Datasea (DTSS) | 10/1/2019 - 12/31/2019 | 217.71% |
Immunitybio (IBRX) | 10/1/2019 - 12/31/2019 | 208.13% |
Aprea Therapeutics (APRE) | 10/1/2019 - 12/31/2019 | 196.83% |
Applied Therapeutics (APLT) | 10/1/2019 - 12/31/2019 | 166.56% |
Nio Inc Class A ADR (NIO) | 10/1/2019 - 12/31/2019 | 166.23% |
Fulcrum Therapeutics (FULC) | 10/1/2019 - 12/31/2019 | 156% |
Comscore (SCOR) | 10/1/2019 - 12/31/2019 | 155.96% |